01 1Xiling Lab
01 1LURBINECTEDIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2026-02-17
Pay. Date : 2026-01-15
DMF Number : 39620
Submission : 2024-09-06
Status : Active
Type : II
20
Xiling Lab Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is LURBINECTEDIN, with a corresponding US DMF Number 39620.
Remarkably, this DMF maintains an Active status since its submission on September 06, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 17, 2026, and payment made on January 15, 2026, indicating their dedication to facilitating drug approvals, Categorized as Type II
